$1000 Invested In Molina Healthcare 15 Years Ago Would Be Worth This Much Today

Molina Healthcare (NYSE:MOH) has outperformed the market over the past 15 years by 4.7% on an annualized basis producing an average annual return of 17.92%. Currently, Molina Healthcare has a market

BenzingaOct 5 22:15

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Vaxcyte (PCVX) and Penumbra (PEN)

TipRanksOct 5 19:31

Trump Offering $90 to Medicare Enrollees to Cover Premiums

Seeking AlphaOct 4 00:33

'Vance-Led Task Force Set to Remove 760,000 Allegedly Fraudulent Obamacare Enrollments' - WSJ Exclusive

'Vance-Led Task Force Set to Remove 760,000 Allegedly Fraudulent Obamacare Enrollments' - WSJ Exclusive

BenzingaSep 22 21:10

Is the pharmaceutical industry ushering in a new narrative? Industry giants are collectively pivoting to AI4S, with high‑profile collaborations at home and abroad and the commercialization of cutting‑edge technologies driving momentum. The AI‑driven drug discovery sector is now entering a critical phase of translating its value into tangible outcomes.

① AI‑drug discovery company Xinsheng Tantú announced the completion of its first‑round angel financing, raising US$290 million; ② From an industry perspective, leveraging AI4S to enter the new‑drug R&D arena has long been a key strategic focus for major players; ③ Guotai Haitong Securities notes that the competitive unit in AI‑drug development is evolving from the molecular level to a system‑level capability encompassing "data × models × pipelines."

CLSSep 17 11:32

Undervalued Healthcare Stocks With Attractive Valuation Grades

Seeking AlphaSep 16 01:15